Difficulty: Medium
Average Score: 62%
Practice
In Acute Leukemia, which of the following is a bad prognostic criterion:
Correct answer
B
Rationale
In Acute Leukemia, leukocytosis greater than 50,000 /cm is a bad prognostic criterion because it indicates a high tumor burden and aggressive disease progression. Elevated white blood cell counts contribute to complications and poorer outcomes in leukemia patients.
Option A (Age more than 2 years) is not a bad prognostic criterion as age alone does not determine the prognosis in acute leukemia. Pediatric patients of varying ages can respond differently to treatment.
Option C (No mediastinal mass) is not a bad prognostic criterion as the presence or absence of a mediastinal mass does not directly correlate with prognosis in acute leukemia.
Option D (No CNS manifestations) is not a bad prognostic criterion as the absence of central nervous system (CNS) manifestations does not necessarily dictate the disease outcome in acute leukemia.
Educationally, understanding prognostic criteria in pediatric leukemia is crucial for nurses caring for these patients. Recognizing these factors helps in early identification of high-risk patients, guiding treatment decisions, and providing appropriate support to optimize outcomes. Leukocytosis is a significant factor to monitor closely in pediatric leukemia cases due to its impact on disease progression and treatment response.
Option A (Age more than 2 years) is not a bad prognostic criterion as age alone does not determine the prognosis in acute leukemia. Pediatric patients of varying ages can respond differently to treatment.
Option C (No mediastinal mass) is not a bad prognostic criterion as the presence or absence of a mediastinal mass does not directly correlate with prognosis in acute leukemia.
Option D (No CNS manifestations) is not a bad prognostic criterion as the absence of central nervous system (CNS) manifestations does not necessarily dictate the disease outcome in acute leukemia.
Educationally, understanding prognostic criteria in pediatric leukemia is crucial for nurses caring for these patients. Recognizing these factors helps in early identification of high-risk patients, guiding treatment decisions, and providing appropriate support to optimize outcomes. Leukocytosis is a significant factor to monitor closely in pediatric leukemia cases due to its impact on disease progression and treatment response.